Hyeon-Gun Jee

Dr. Hyeon-Gun Jee

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Laboratory Animal Research
Verified
Journal Article
Open access
PDF file
KLKyu Eun Lee
Kyu Eun Lee
HJHyeon-Gun Jee
Hyeon-Gun Jee
HKHoon-Yub Kim
Hoon-Yub Kim
WPWon-Seo Park
Won-Seo Park
SPSung-Hye Park
Sung-Hye Park
YYYeo-Kyu Youn
Yeo-Kyu Youn
Lee KE, et al. Lab Anim Res. 2012 Dec;28(4):223-228. https://doi.org/10.5625/lar.2012.28.4.223

18 February 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
HJHyeon-Gun Jee
Hyeon-Gun Jee
BKByoung-Ae Kim
Byoung-Ae Kim
MKMinjun Kim
Minjun Kim
HYHyeong Won Yu
Hyeong Won Yu
JCJune Young Choi
June Young Choi
KLKyu Eun Lee
Kyu Eun Lee
Preoperative diagnosis of thyroid nodules reduces unnecessary surgery. Circulating tumor cells (CTCs) may contain information of primary tumor(s). We asked whether the peripheral blood expression of genes specific for circulating tumor cells (CTCs) differentiates benign thyroid nodules from malignant nodules. Peripheral blood mononuclear cells from thyroid nodule patients (n = 20) were isolated preoperatively and the expression of seven CTC-associated genes was measured in patients with thyroid nodule(s) (n = 20). Among the tested genes, the expression of SLC5A5 and LGALS3 were validated in a larger number of patients (n = 64) and our results show that SLC5A5 expression differentiated follicular adenomas from follicular carcinomas (area under the curve (AUC) = 0.831). The expression of SLC5A5 in CTCs may preoperatively distinguish thyroid follicular adenomas from follicular carcinomas.

4 May 2022 in Clinical and Experimental Otorhinolaryngology
Verified
Journal Article
Open access
PDF file
JYJin Wook Yi
Jin Wook Yi
SHSeong Yun Ha
Seong Yun Ha
HJHyeon-Gun Jee
Hyeon-Gun Jee
KWANGSOO KIMKWANGSOO KIM
KWANGSOO KIM
SKSu-jin Kim
Su-jin Kim
KLKyu Eun Lee
Kyu Eun Lee
Objectives. The BRAFV600E mutation is a major driver mutation in papillary thyroid cancer. The aim of this study was to elucidate the correlation between DNA methylation and gene expression changes induced by the BRAFV600E mutation in thyroid cells.Methods. We used Nthy/BRAF cell lines generated by transfection of Nthy/ori cells with the wild-type BRAF gene (Nthy/WT cells) and the V600E mutant-type BRAF gene (Nthy/V600E cells). We performed gene expression microarray and DNA methylation array analyses for Nthy/WT and Nthy/V600E cells. Two types of array data were integrated to identify inverse correlations between methylation and gene expression. The results were verified in silico using data from The Cancer Genome Atlas (TCGA) and in vivo through pyrosequencing and quantitative real-time polymerase chain reaction (qRT-PCR).Results. In the Nthy/V600E cells, 199,821 probes were significantly hypermethylated, and 697 genes showed a “hypermethylation-downregulation” pattern in Nthy/V600E. Tumor suppressor genes and apoptosis-related genes were included. In total, 66,446 probes were significantly hypomethylated, and 227 genes showed a “hypomethylation-upregulation” pattern in Nthy/V600E cells. Protooncogenes and developmental protein-coding genes were included. In the TCGA analysis, 491/697 (70.44%) genes showed a hypermethylation-downregulation pattern, and 153/227 (67.40%) genes showed a hypomethylation-upregulation pattern. Ten selected genes showed a similar methylation-gene expression pattern in pyrosequencing and qRT-PCR.Conclusion. Induction of the BRAFV600E mutation in thyroid cells led to frequent hypermethylation. Anticancer genes, such as those involved in tumor suppression or apoptosis, were downregulated by upstream hypermethylation, whereas carcinogenic genes, such as protooncogenes, were upregulated by hypomethylation. Our results suggest that the BRAFV600E mutation in thyroid cells modulates DNA methylation and results in cancer-related gene expression.

1 May 2019 in Clinical Interventions in Aging
Verified
Journal Article
Open access
PDF file
JKJi-Youn Kim
Ji-Youn Kim
HSHyun Chul Song
Hyun Chul Song
HJHyeon-Gun Jee
Hyeon-Gun Jee
Purpose: Osteonecrosis of the jaw (ONJ), both medication-related and non medication-related, mainly occurs in aged patients. It needs surgical intervention. Refractory healing after an operation of ONJ can significantly lower the quality of life of elderly patients. The purpose of this study was to determine risk factors associated with refractory healing in aged patients. Patients and methods: We performed a retrospective study of ONJ in aged patients who underwent surgical treatments in a single institute during a 12-year period. Multiple logistic regression analysis was used to determine independent risk factors associated with refractory healing. Results: A total of 122 patients were included. Of them, 25 patients were identified as the refractory group and 97 patients as the control group. Diabetes mellitus (DM) (AOR=5.03, 95% CI: 1.74–14.52) and glucocorticoid administration (AOR=7.97, 95% CI: 2.52–25.23) were found to be significant risk factors for refractory healing of ONJ. Conclusion: DM and medication of glucocorticoid might be risk factors for refractory healing of ONJ.